Two failed cancer studies this week provided a fresh reminder how little researchers and clinicians understand about immunotherapy’s vagaries: why it works for some people and not for others.
The results, in lung cancer and head-and neck cancer, add to recent... Read more »
Despite all the great progress made harnessing the immune system to fight cancer, there is still much work to be done to maximize its potential. The latest evidence: disappointing results today from a roughly 1,100-patient study called “Mystic,” a highly anticipated... Read more »
Austin—Peter Kirby describes his foray into entrepreneurship as “following threads of curiosity.”
“That’s always led me to interesting places,” he says. “In this case, my curiosity was around Bitcoin.” That led him to Factom, a blockchain startup in Austin for... Read more »
The attempt to repeal and replace the Affordable Care Act took a major hit this week from Senate GOP holdouts who said the Better Care Reconciliation Act either tore down Medicaid too much or left too much of the ACA in... Read more »
[Updated 7/25/17 5:18 pm. See below.] Houston—Houston, Mission Control has a problem.
The storied control room at NASA’s Johnson Space Center in Houston—recognizable to many of us from 1960s news clips of the dawn of the Space... Read more »
The second episode of Xconomy’s new podcast, Xconomy Voices, features Recorded Future co-founder and CEO Christopher Ahlberg. His Somerville, MA-based cybersecurity company monitors both the public, visible Web and the Internet’s darker corners for “threat intelligence” that can help... Read more »
On our new Xconomy Voices podcast, we find the smartest, most successful entrepreneurs and innovators in Xconomy’s network of cities and regions, and we ask them to open up about what they’re working on, what they’re excited about, and why... Read more »
The Internet pioneer Vinton Cerf came to San Diego recently on an unusual quest—to meet with dozens of local technology leaders and assess what the region has to offer in terms of innovation. It was Veni, Vidi, Vinti. He came. He... Read more »
Amazon and Techstars announced the nine companies selected for the Amazon Alexa Accelerator, which began its initial 13-week program in Seattle Monday.
Why it matters: Seattle is already a hub of artificial intelligence research and commercialization activity at technology giants... Read more »
The Detroit-based Techstars Mobility program announces its third cohort today, and managing director Ted Serbinski says it’s the most international class yet with startups from five countries. There are also new corporate partners coming on board and additions to the accelerator’s... Read more »
Government and industry are rife with awkward acronyms. Take PDUFA, for example.
First passed in 1992, the Prescription Drug User Fee Act allows the FDA to collect fees from biopharmaceutical companies when they apply for drug approval; those funds are designated... Read more »
The first ever approval of a new kind of cancer immunotherapy called CAR-T is one step closer. A 10-member panel of doctors and researchers who advise the Food and Drug Administration recommended with a rare unanimous vote that the agency approve... Read more »